Trial Profile
A phase I study of PTX 9908 for the treatment of liver cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs PTX 9908 (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 16 Feb 2016 New trial record